Allenex is a life science company that develops, manufactures, markets and sells high quality products and services that facilitate safer transplantations with better results.
Allenex vision is to be a leader in its market segment with abroad product portfolio that solves major unmet medical needs. In addition to existing products for diagnostics and matching in organ and hematopoietic stem cell transplantation, Allenex intends to offer a complementary range of products and services that increase the potential of successful transplantation. Allenex aims for its products and services to be a first choice for medical centers and laboratories in the industry.
To create the conditions for becoming a leading global player in the transplantation sector and focus on growth and profitability through:
Allenex long-term goal is to build a successful global transplantation-sector company with strong growth potential.
Allenex financial objectives are to increase consolidated turnover in one business cycle by an average of at least 10 percent per year, with an EBIT operating margin that exceeds 20 percent.